On August 20, Nordson rose 6.8% overnight, trading at $331.0/share, with turnover of $9,930. The stock surged following the release of record-breaking fiscal third-quarter results that exceeded market expectations across all key metrics, accompanied by an upward revision to full-year guidance.

For the quarter ended July 31, Nordson reported adjusted earnings per share of $3.25, beating the analyst consensus estimate of $3.09-$3.10 by approximately 5%, and representing a 19.05% increase from $2.73 in the year-ago period. Quarterly revenue reached a record $817.67 million, surpassing the expected $780 million and growing 10% year-over-year. Organic sales growth was approximately 12%, driven by broad-based strength across all business segments.

The company raised its fiscal full-year sales guidance to a range of $3.035 billion to $3.075 billion, meaningfully above the prior FactSet consensus estimate of $2.98 billion. The combination of top-line momentum and margin expansion underscores robust demand across Nordson's precision dispensing, medical, and advanced technology end markets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)